Craig C. Hopkinson - Dec 1, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Dec 1, 2022
Transactions value $
$0
Form type
4
Date filed
12/5/2022, 03:10 PM
Previous filing
Feb 24, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Award $0 +10.5K $0.00 10.5K Dec 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs will vest in equal annual installments over three years from December 1, 2022 (but, in any case, to be fully vested on the day prior to the annual meeting for the third fiscal year that begins following the date of grant), subject to the director's continued service on the issuer's board of directors on the applicable vesting dates.
F2 Represents 10,495 restricted stock units.